Cargando…

Evaluation of point‐of‐care thoracic ultrasound and NT‐proBNP for the diagnosis of congestive heart failure in cats with respiratory distress

BACKGROUND: The diagnosis of congestive heart failure (CHF) in cats is challenging. Point‐of‐care (POC) thoracic ultrasound and NT‐proBNP testing are emerging tools that may aid in diagnosis. HYPOTHESIS/OBJECTIVES: To assess the diagnostic accuracy of POC lung ultrasound (LUS), focused cardiac ultra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ward, Jessica L., Lisciandro, Gregory R., Ware, Wendy A., Viall, Austin K., Aona, Brent D., Kurtz, Kari A., Reina‐Doreste, Yamir, DeFrancesco, Teresa C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2018
Materias:	SMALL ANIMAL
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6189386/ https://www.ncbi.nlm.nih.gov/pubmed/30216579 http://dx.doi.org/10.1111/jvim.15246

Ejemplares similares

Association between Survival Time and Changes in NT‐proBNP in Cats Treated for Congestive Heart Failure
por: Pierce, K.V., et al.
Publicado: (2017)

Effect of prespecified therapy escalation on plasma NT‐proBNP concentrations in dogs with stable congestive heart failure due to myxomatous mitral valve disease
por: Hezzell, Melanie J., et al.
Publicado: (2018)

Differentiation of Cardiac from Noncardiac Pleural Effusions in Cats using Second‐Generation Quantitative and Point‐of‐Care NT‐proBNP Measurements
por: Hezzell, M.J., et al.
Publicado: (2016)

Plasma NT‐proBNP and Cell‐Free DNA Concentrations after Prolonged Strenuous Exercise in Working Farm Dogs
por: Hunt, H., et al.
Publicado: (2017)

Thirteen dogs and a cat with ultrasonographically detected gallbladder wall edema associated with cardiac disease
por: Lisciandro, Gregory R., et al.
Publicado: (2021)

Detection of congestive heart failure by Doppler echocardiography in cats with hypertrophic cardiomyopathy
por: Rohrbaugh, Michelle N., et al.
Publicado: (2020)

Die Biomarker BNP und NT‑proBNP
por: Oremek, G. M., et al.
Publicado: (2023)

Cardiorenal and endocrine effects of synthetic canine BNP1‐32 in dogs with compensated congestive heart failure caused by myxomatous mitral valve disease
por: Yata, Mariko, et al.
Publicado: (2019)

Utility of point‐of‐care lung ultrasound for monitoring cardiogenic pulmonary edema in dogs
por: Murphy, Shane D., et al.
Publicado: (2020)

Cardiac cachexia in cats with congestive heart failure: Prevalence and clinical, laboratory, and survival findings
por: Santiago, Sasha L., et al.
Publicado: (2019)

Cardiovascular‐renal axis disorder and acute‐phase proteins in cats with congestive heart failure caused by primary cardiomyopathy
por: Liu, Mengmeng, et al.
Publicado: (2020)

Relative Change in NT-proBNP Level: An Important Risk Predictor of Cardiovascular Congestion in Haemodialysis Patients
por: Pastural-Thaunat, M., et al.
Publicado: (2012)

Agreement of BNP and NT-proBNP and the influence of clinical and laboratory variables
por: Curiati, Milena Novaes Cardoso, et al.
Publicado: (2013)

Retrospective evaluation of the safety and tolerability of pimobendan in cats with obstructive vs nonobstructive cardiomyopathy
por: Ward, Jessica L., et al.
Publicado: (2020)

Development of a Rapid Diagnostic Kit for Congestive Heart Failure Using Recombinant NT-proBNP Antigen
por: Lee, Young-Ki, et al.
Publicado: (2021)

Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure
por: Palazzuoli, A, et al.
Publicado: (2010)

Effects of pimobendan in cats with hypertrophic cardiomyopathy and recent congestive heart failure: Results of a prospective, double‐blind, randomized, nonpivotal, exploratory field study
por: Schober, Karsten E., et al.
Publicado: (2021)

Vitamin D status in cats with cardiomyopathy
por: Ware, Wendy A., et al.
Publicado: (2020)

Radiographic lung congestion scores in dogs with acute congestive heart failure caused by myxomatous mitral valve disease
por: Koster, Liza, et al.
Publicado: (2023)

The Ability of Heart Failure Specialists to Accurately Predict NT-proBNP Levels Based on Clinical Assessment and a Previous NT-proBNP Measurement
por: Sedlak, Tara L, et al.
Publicado: (2008)

BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing?
por: Lewis, Robert A., et al.
Publicado: (2020)

Use of NT-proBNP in weaning from mechanical ventilation
por: Martini, A, et al.
Publicado: (2011)

NT-proBNP and the diagnosis of exercise-induced myocardial ischaemia
por: De Greef, Jacques, et al.
Publicado: (2008)

Rise and fall of NT-proBNP in aortic valve intervention
por: Hultkvist, Henrik, et al.
Publicado: (2018)

Highly sensitive detection of NT-proBNP by molecular motor
por: Zhang, Jie, et al.
Publicado: (2016)

In-hospital mortality is associated with high NT-proBNP level
por: Benmachiche, Malik, et al.
Publicado: (2018)

Admission NT-ProBNP in Myocardial Infarction: an Alert Sign?
por: da Silva, Luís Beck
Publicado: (2019)

The Potential Role of Salivary NT-proBNP in Heart Failure
por: Rammos, Aidonis, et al.
Publicado: (2023)

Evaluation of oral telmisartan administration as a suppression test for diagnosis of primary hyperaldosteronism in cats
por: Fabrès, Virginie, et al.
Publicado: (2023)

Juvenile‐onset motor polyneuropathy in Siberian cats
por: Crawford, Kelly C., et al.
Publicado: (2020)

Circulating renin‐angiotensin‐aldosterone system activity in cats with systemic hypertension or cardiomyopathy
por: Ward, Jessica L., et al.
Publicado: (2022)

Alendronate treatment in cats with persistent ionized hypercalcemia: A retrospective cohort study of 20 cases
por: Kurtz, Maxime, et al.
Publicado: (2022)

Correction of serum chloride concentration in dogs with congestive heart failure
por: Adin, Darcy, et al.
Publicado: (2020)

Toward quantification of loop diuretic responsiveness for congestive heart failure
por: Oyama, Mark A., et al.
Publicado: (2022)

BNP and NT-proBNP as Diagnostic Biomarkers for Cardiac Dysfunction in Both Clinical and Forensic Medicine
por: Cao, Zhipeng, et al.
Publicado: (2019)

Towards Point-of-Care Heart Failure Diagnostic Platforms: BNP and NT-proBNP Biosensors
por: Alawieh, Hussein, et al.
Publicado: (2019)

Prospective evaluation of a telmisartan suppression test as a diagnostic tool for primary hyperaldosteronism in cats
por: Kurtz, Maxime, et al.
Publicado: (2023)

Does dipyridamole-induced ischaemia affect NT-proBNP secretion?
por: De Greef, Jacques, et al.
Publicado: (2007)

Using NT-proBNP as a criterion for heart failure hospitalization
por: Tamizifar, Babak, et al.
Publicado: (2012)

NT-proBNP in Children With Left to Right Shunt and Dilated Cardiomyopathy
por: Koura, Hala Mahmoud, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_e07upsad3jfhe4llburhue6cpk